Study identifier:NIS-GTH-NEX-2009/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Prevalence of GERD in Patients with upperGITsymptoms in Thailand
Upper GIT symptoms
-
No
-
All
4108
Observational
18 Years +
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Jan 2015 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
This is a prospective , epidemiological, multi-centre, phase IV study, approximately 5,000 patients who suffer with upper gastrointestinal tract symptoms. Each patient will be assessed for GERD with GerdQ Thai Version.
Location
Location
Bangkok Noi, Bangkok, Thailand
Location
Klong Luang, Pathumthani, Thailand
Location
Maerim, Chiang Mai, Thailand
Location
Maung, Chiang Mai, Thailand
Location
Maung, Khon Kaen, Thailand
Location
Maung, Nakhon Sri Thammarat, Thailand
Location
Maung, NAKHONRATCHASIMA, Thailand
Location
Maung, Nakhonsawan, Thailand
Arms | Assigned Interventions |
---|
This information is not intended to replace the informed medical advice or medical treatments of a healthcare professional. Only a physician can determine if a specific medicine is the correct treatment for a particular patient. If you have questions regarding any information contained in this site, you must consult a suitably qualified healthcare professional. Before prescribing any AstraZeneca products, Healthcare Professionals should view their country specific information.